在温哥华一组注射吸毒者中,使用冰毒与非致命过量用药有关。
Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver.
作者信息
Fairbairn Nadia, Wood Evan, Stoltz Jo-Anne, Li Kathy, Montaner Julio, Kerr Thomas
机构信息
British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC Canada, V6Z 146.
出版信息
Public Health. 2008 Jan;122(1):70-8. doi: 10.1016/j.puhe.2007.02.016. Epub 2007 Jul 23.
OBJECTIVES
To evaluate the prevalence and correlates of non-fatal overdose among a polysubstance-using cohort of injection drug users (IDU) in Vancouver.
STUDY DESIGN/METHODS: We evaluated factors associated with non-fatal overdose among participants enrolled in the Vancouver Injection Drug Users Study (VIDUS) using univariate statistics. Self-reports of the awareness of drugs taken and drug potency, polysubstance use, and assistance received at the time of non-fatal overdose were also recorded.
RESULTS
From 1 December 2003 to 1 June 2005, 551 participants who were active injectors were followed. In total, 37 (6.7%) individuals reported experiencing a non-fatal overdose in the previous 6 months. Factors positively associated with non-fatal overdose included public injecting (odds ratio (OR)=4.74, 95% confidence interval (CI) 2.35-9.37, P<0.001), crystal methamphetamine use (OR=4.11) and injection (OR=3.63), morphine injection (OR=3.55), non-injection opiate use (OR=3.30), frequent heroin injection (OR=2.28) and sex trade work (OR=2.12). Factors negatively associated with non-fatal overdose included participation in methadone maintenance therapy (OR=0.31) and injecting alone (OR=0.36). Sixty-two percent of individuals were unaware of drug potency, 64.9% of IDU were taking other drugs at the time of overdosing, with crack being the main drug (37.0%). Fifty-four percent were assisted by ambulance personnel, 56.8% were taken to accident and emergency or hospital, 38.1% left accident and emergency or hospital before being released, and 35.1% were given Naloxone.
CONCLUSION
Structural interventions are needed that seek to modify the social and contextual risks for overdose, increased access to treatment programmes, and trials of novel interventions for crystal methamphetamine users.
目的
评估温哥华多药滥用注射吸毒者(IDU)队列中非致命过量用药的患病率及其相关因素。
研究设计/方法:我们使用单变量统计评估了参与温哥华注射吸毒者研究(VIDUS)的参与者中非致命过量用药的相关因素。还记录了非致命过量用药时所服用药物及药效的知晓情况、多药滥用情况以及获得的帮助的自我报告。
结果
2003年12月1日至2005年6月1日,对551名活跃注射者进行了随访。共有37人(6.7%)报告在过去6个月中经历过非致命过量用药。与非致命过量用药呈正相关的因素包括公共场合注射(优势比(OR)=4.74,95%置信区间(CI)2.35 - 9.37,P<0.001)、使用冰毒(OR = 4.11)和注射(OR = 3.63)、注射吗啡(OR = 3.55)、非注射类阿片使用(OR = 3.30)、频繁注射海洛因(OR = 2.28)和从事性交易工作(OR = 2.12)。与非致命过量用药呈负相关的因素包括参加美沙酮维持治疗(OR = 0.31)和单独注射(OR = 0.36)。62%的人不知道药物药效,64.9%的注射吸毒者在过量用药时还服用其他药物,其中快克是主要药物(37.0%)。54%的人得到了救护人员的帮助,56.8%的人被送往急诊室或医院,38.1%的人在出院前离开急诊室或医院,35.1%的人接受了纳洛酮治疗。
结论
需要采取结构性干预措施,以改变过量用药的社会和环境风险,增加获得治疗项目的机会,并对冰毒使用者进行新型干预试验。